PCSA logo

Processa Pharmaceuticals (PCSA) Retained Earnings

Annual Retained Earnings

-$75.37 M
-$11.12 M-17.31%

31 December 2023

PCSA Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Retained Earnings

-$84.49 M
-$3.38 M-4.17%

30 September 2024

PCSA Quarterly Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PCSA Retained Earnings Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-17.3%-15.8%
3 y3 years-196.8%-151.2%
5 y5 years-888.6%-727.7%

PCSA Retained Earnings High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-196.8%at low-151.2%at low
5 y5 years-888.6%at low-727.7%at low
alltimeall time-7908.6%at low-3136.6%at low

Processa Pharmaceuticals Retained Earnings History

DateAnnualQuarterly
Sept 2024
-
-$84.49 M(+4.2%)
June 2024
-
-$81.11 M(+3.9%)
Mar 2024
-
-$78.10 M(+3.6%)
Dec 2023
-$75.37 M(+17.3%)
-$75.37 M(+3.3%)
Sept 2023
-
-$72.96 M(+2.9%)
June 2023
-
-$70.88 M(+3.8%)
Mar 2023
-
-$68.27 M(+6.3%)
Dec 2022
-$64.25 M(+74.5%)
-$64.25 M(+25.4%)
Sept 2022
-
-$51.24 M(+13.3%)
June 2022
-
-$45.21 M(+12.9%)
Mar 2022
-
-$40.05 M(+8.8%)
Dec 2021
-$36.82 M(+45.0%)
-$36.82 M(+9.5%)
Sept 2021
-
-$33.64 M(+9.7%)
June 2021
-
-$30.65 M(+11.5%)
Mar 2021
-
-$27.50 M(+8.3%)
Dec 2020
-$25.40 M(+131.2%)
-$25.40 M(+62.2%)
Sept 2020
-
-$15.66 M(+24.4%)
June 2020
-
-$12.59 M(+6.2%)
Mar 2020
-
-$11.86 M(+8.0%)
Dec 2019
-$10.98 M(+44.0%)
-$10.98 M(+7.6%)
Sept 2019
-
-$10.21 M(+9.2%)
June 2019
-
-$9.34 M(+11.6%)
Mar 2019
-
-$8.38 M(+9.8%)
Dec 2018
-$7.62 M
-$7.62 M(+8.7%)
Sept 2018
-
-$7.01 M(+13.8%)
DateAnnualQuarterly
June 2018
-
-$6.16 M(+24.3%)
Mar 2018
-
-$4.96 M(+28.4%)
Dec 2017
-$3.86 M(-74.7%)
-$3.86 M(-77.3%)
Sept 2017
-
-$17.04 M(+10.7%)
June 2017
-
-$15.39 M(+0.3%)
Mar 2017
-
-$15.34 M(+0.6%)
Dec 2016
-$15.25 M(+2.6%)
-$15.25 M(+0.7%)
Sept 2016
-
-$15.15 M(+0.5%)
June 2016
-
-$15.07 M(+0.4%)
Mar 2016
-
-$15.02 M(+1.0%)
Dec 2015
-$14.87 M(+25.5%)
-$14.87 M(-6.6%)
Sept 2015
-
-$15.93 M(+2.0%)
June 2015
-
-$15.62 M(+15.2%)
Mar 2015
-
-$13.56 M(+14.4%)
Dec 2014
-$11.85 M(+73.9%)
-$11.85 M(+18.5%)
Sept 2014
-
-$10.00 M(+9.5%)
June 2014
-
-$9.13 M(+11.1%)
Mar 2014
-
-$8.22 M(+20.6%)
Dec 2013
-$6.81 M(+98.6%)
-$6.81 M(+14.4%)
Sept 2013
-
-$5.96 M(+18.4%)
June 2013
-
-$5.03 M(+17.7%)
Mar 2013
-
-$4.28 M(+24.7%)
Dec 2012
-$3.43 M(+264.6%)
-$3.43 M(+31.4%)
Sept 2012
-
-$2.61 M
Dec 2011
-$941.10 K
-

FAQ

  • What is Processa Pharmaceuticals annual retained earnings?
  • What is the all time high annual retained earnings for Processa Pharmaceuticals?
  • What is Processa Pharmaceuticals annual retained earnings year-on-year change?
  • What is Processa Pharmaceuticals quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Processa Pharmaceuticals?
  • What is Processa Pharmaceuticals quarterly retained earnings year-on-year change?

What is Processa Pharmaceuticals annual retained earnings?

The current annual retained earnings of PCSA is -$75.37 M

What is the all time high annual retained earnings for Processa Pharmaceuticals?

Processa Pharmaceuticals all-time high annual retained earnings is -$941.10 K

What is Processa Pharmaceuticals annual retained earnings year-on-year change?

Over the past year, PCSA annual retained earnings has changed by -$11.12 M (-17.31%)

What is Processa Pharmaceuticals quarterly retained earnings?

The current quarterly retained earnings of PCSA is -$84.49 M

What is the all time high quarterly retained earnings for Processa Pharmaceuticals?

Processa Pharmaceuticals all-time high quarterly retained earnings is -$2.61 M

What is Processa Pharmaceuticals quarterly retained earnings year-on-year change?

Over the past year, PCSA quarterly retained earnings has changed by -$11.53 M (-15.80%)